566th MEETING, CAMBRIDGE 149 saccharide transport across the erythrocyte membrane (Stein, 1967) ; the K,,, for D-glucose transport is 3-5 mM, whereas that for L-glucose is higher than 3 M. Table 1 contains a selection of the permeability results obtained. The final column records the ratio of the permeabilities of the sugars to the passive permeabilities in the absence of membrane extracts. In the absence of sugar-transport inhibitors all the extracts containing Bands 3 and 4.2 enhanced the permeability of black lipid membranes to D-glucose. We could not establish a clear relationship between the extent of enhancement and the protein concentration in the solution bathing the membrane. The results varied depending on the extract and membrane, but enhancement occurred in over 20 different experiments. Addition of both irreversible (p-chloromercuribenzenesulphonate, pchloromercuribenzoate and HgCI,) and competitive (phloretin and 2-deoxy-~-glucose) inhibitors lowered the membrane permeabilities to values corresponding to passive diffusion, although the result for 2-deoxy-~-g~ucose is slightly higher than expected. Spectrin, Band-6 polypeptides and membrane lipids that co-purify with Band 3 have no effect on the permeability, and at a concentration comparable with that in the extracts Triton X-100 only marginally enhances the permeability.
Recent experiments have demonstrated the existence of a layer of H+ at the surface of rat and human proximal jejunum whose pH is more than 1 unit lower than and not in equilibrium with the pH of incubation buffers (Lucas et at., 1975) . The present experiments deaf with the reIationship between the surface and bulk pH over a wide range of bulk pH, i.e. the ability of the gut to maintain the luminal surface at a constant pH despite pH fluctuations in the immediate lurninal environment. The methods have been reported in detail elsewhere (Lucas et ul.) and consist of pH investigations in uitro on flat squares of rat proximal jejunum with pH electrodes having convex surface capable of measuring a depth of 30,um.
Incubation of samples at 37°C in Krebs/phosphate buffer (under 100% 0,) containing 10mM-glucose and adjusted to various pH values with 1 M-HCI or 1 M-NaOH gave the results shown in Fig. 1 Line of identity between the surface and bulk pH.
-+s.E.M., number of determinations in parentheses). At a more alkaline bulk solution pH of 8.35*0.13(6), the surface pH is 6.29*0.16(6) and the difference becomes even more striking: a difference of 2 pH units i s observed, representing a 100-fold concentration difference. The equilibrium pH when the bulk and surface pH have the same value is about 5.5. When the bulk medium is excessively acidified to values between 2 and 4, there are no obvious differences between bulk and surface pH. Initially, the surface pH at the onset of incubation can be significantly less acid than the bulk pH, but with time becomes isohydric. This may reflect alimitedability to control thesurfacepHagainst acid fluctuations, or more likely the time needed for H+ to diffuse into the surface layer from the more acid bulk phase. This response of the jejunal surface is unchanged over a 1 h incubation period or by replacing phosphate with bicarbonate buffer. The effects of various compounds, including some of interest in the transport of folic acid, were tested. Fig. 2 shows the effect of low-sodium buffer (containing 30m~-Na+), the administration by intraperitoneal injection of methotrexate (2mg) before the experiment and at a concentration of 1 j i~ in uitro, in phosphate buffer containing l0mM-glucose. Results are expressed as the difference in pH above the control value (5.7) with standard errors of the difference between means. Low-sodium buffer (P<O.O5) causes a significant increase in surface pH; since the condition decreases glucose transfer in vitro (Faust, 1962) , this probably reflects a decrease in access to glucose, a substrate known to affect surface pH maintenance. Methotrexate added in vitro had no effect on the pH; in contrast, methotrexate administered 24h before the experiment caused an elevation (P <0.05) in surface pH. The present experiments demonstrate the existence of a mechanism in the proximal jejunum that maintains the surface pH at a low pN despite excessive luminal alkalinity. Since many substances have ionizable groups with a pK. well below physiological pH, e.g. amino acids, fatty acids and several water-soluble vitamins, the maintenance of such a low surface pH would facilitate absorption of neutral forms by non-ionic diffusion. A control mechanism coming into effect when excessive alkalinity occurs, as has been demonstrated, would achieve this facilitation of diffusion; this may represent 'finetuning' of luminal pH after duodenal neutralization of the gastric contents as they move down the small bowel. This secretion of H+ at the gut surface in response to alkalinity implies the involvement of an enzyme which is increasingly active above pH5.7, e.g. alkaline phosphatase or mucosally situated (Na+ +K+)-stimulated adenosine triphosphatase.
The effects of low-sodium buffer confirm that the maintenance of a low surface pH is dependent on adequate tissue metabolism. Since this condition as well as the presence of aminophylline, ouabain and glucose affect the surface pH, care must be taken in interpreting the results of transport experiments in vitro involving compounds with ionizable groups. One might except accelerated transfer of weak electrolytes, e.g. amino acids and fatty acids, on adding glucose to the medium, and a decrease in transfer owing to decreased sodium concentration; this may lead to being erroneously interpreted as demonstrating the existence of specific transport systems or carrier specificities or the involvement of the known systems that inhibitors affect. Where compounds are transferred in small quantities, unspecific tissue binding can lead to tissue/ VOl. 5 medium concentration ratios greater than one; the further effects of glucose and metabolic inhibitors may show an unspecific dependence on metabolism, leading to two of the criteria for active transport becoming apparent, without active transport actually having taken place.
The effect of methotrexate on surface pH could explain conflicting reports about its effect; studies in vitro have demonstrated no effect on folic acid transfer in contrast with the results of Hepner (1 969), who administered methotrexate subcutaneously before the experiment. Prior administration would allow methotrexate to exercise its metabolic effect and elevate the surface pH, allowing less folic acid to be transferred by non-ionic diffusion, an effect not seen in vitro.
